Janngo Capital

Janngo Capital is a pan-African venture firm operating from Abidjan that closed an oversubscribed second fund of $78M in late 2024, making it one of Africa’s largest gender-equal tech VCs. The fund writes checks from $50k to $5M across Seed and Series A, with healthcare as a core sector alongside logistics, financial services, retail, food and agriculture, mobility, and the creator economy. Roughly 56 percent of its portfolio is women-led, and the fund explicitly targets companies that improve access to essential goods and services. For healthcare founders, the relevant surfaces include digital health platforms, telemedicine, women’s and reproductive health, care delivery infrastructure, and AI applications layered onto African clinical and claims data. The right founder is an African technical or commercial operator, ideally with a gender-balanced founding team or an explicit gender-impact thesis, building a tech-enabled platform that solves a real access problem in healthcare. Founders pursuing biotech, MedTech with multi-year clearance pathways, or pure consumer wellness brands should look elsewhere. Geographic advantage is genuine pan-African coverage, with active deals across Francophone West Africa, Nigeria, Kenya, Egypt, and South Africa. The Abidjan center of gravity also gives Janngo an edge in markets that diaspora-only or anglophone-only funds underweight, including Cote d’Ivoire, Senegal, and broader UEMOA. The fund’s TIME100 recognition and DFI-backed LP base reflect institutional credibility that helps with regulator and corporate introductions. Best entry path is a warm intro from a portfolio founder or a known African co-investor; the fund’s positioning means it sees a high volume of impact-oriented inbound, so a sharper signal on revenue and unit economics is what differentiates conversations. Lead the pitch with a clear access problem, real revenue, and a credible pan-African expansion logic. AI healthcare founders should describe the data asset, training methodology, and how patient consent and data residency are handled under emerging African data protection regimes. Caveats: the impact and gender-equal mandate is genuine, so founders without an authentic alignment should not contort the narrative to fit, since LP reporting will surface the gap. Ask Janngo directly about reserves, prorata behavior, and which Series A leads it has brought into portfolio companies. Confirm the fund’s check pace and remaining deployment, since the Fund II vintage is still relatively young. Reference checks with current portfolio CEOs on speed of decisions and operating support are essential. Used appropriately, Janngo is one of the most credible African early-stage partners for healthcare and digital access founders today.